Showing results (321-330 of 364) with videos related to

Sort By:
Pageof 37
The Diabetes Educator|May 28, 2005
Diabetes management in San Diego's Chamorro communityPhillis L Wu, Georgia Robins Sadler, Victoria Nguyen, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
Dermatology and Therapy|May 9, 2024
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 AnalysisLeon H Kircik, Linda Stein Gold, Michael Gold, et al.
Contemporary Clinical Trials Communications|April 22, 2026
Addressing financial and health-related social needs among patients with cancer: Study protocol for CAN-ASSIST pilot clinical trialMaedeh Sharifian, Victoria Nguyen, Aarushi Madan, et al.
Italian Journal of Pediatrics|March 4, 2016
Consensus Conference on Clinical Management of pediatric Atopic DermatitisElena Galli, Iria Neri, Giampaolo Ricci, et al.
Pediatric Dermatology|January 17, 2020
Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter databaseLeila H Shayegan, Laura E Levin, Eloise R Galligan, et al.
Experimental and Molecular Pathology|September 17, 2002
The role of the ubiquitin-proteasome pathway in the formation of mallory bodiesFawzia Bardag-Gorce, Frederik Willen van Leeuwen, Victoria Nguyen, et al.
Pediatric Dermatology|November 28, 2020
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes databaseLaura E Levin, Leila H Shayegan, Anne W Lucky, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension TrialEric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
Pageof 37